Home Exo Therapeutics

Exo Therapeutics

In operation
Series B
Small Molecule Drug Developer
Basic
Enterprise Profile

Basic Information

Exo Therapeutics is a small-molecule drug discovery and development company with pioneering technology to address challenging drug targets. By leveraging the company’s ExoSight™ platform, Exo is developing a robust pipeline of drug candidates that can bind to exosites, distal and unique binding pockets, potentially reprogramming enzyme activity for precise and powerful therapeutic effects. Through this selective approach to targeting challenging objectives, the company’s world-class research team is pioneering breakthrough therapies in oncology, inflammation, and other broad disease areas.
Exo Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2018
info@exo-therapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs